PGY-2 Oncology Residency Program

Program description

The Dartmouth Cancer Center at Dartmouth Hitchcock Medical Center is a National Cancer Institute (NCI) designated comprehensive cancer center. Our pharmacy residency in oncology is a 52-week, full-time, post-graduate year two (PGY-2) training program. The oncology pharmacy residency will expose the resident to challenging and diverse patient populations across a variety of care settings including both inpatient and ambulatory oncology.

The primary goals of the PGY-2 Oncology Pharmacy Residency Program are to:

• Incorporate the resident as part of a multidisciplinary team to improve care of adult and pediatric oncology patients.
• Offer a diverse amount of experiences, allowing the resident to gain exposure in a variety of oncology care settings.
• Prepare the resident to enter the workforce as a clinical specialist, faculty member, or in a leadership role.
• Offer a flexible program, allowing the resident to explore individual interest areas.
• Prepare the resident to take the Board Certified Oncology Pharmacist (BCOP) examination upon graduation from the program.

Required learning experiences

• Ambulatory hematology
• Ambulatory oncology
• Inpatient hematology
• Investigational pharmacy
• Oral chemotherapy specialty pharmacy
• Orientation
• Palliative care
• Pediatric hematology/oncology
• Practice management
• Transplantation and cellular therapy

Elective learning experiences

• Ambulatory hematology/oncology - Satellite-based care
• Benign hematology
• Infectious disease
• Nutrition
• Repeat of a required rotation

Longitudinal learning experiences

• Clinical development
• Medication use evaluation
• Precepting/education
• Research project
• Staffing

Additional responsibilities

Committee involvement

The resident will serve as an active member on both the Hematology/Oncology Drug and Practice Specialty P&T Panel and the Dartmouth Cancer Center Medication Safety Committee.

Medication use evaluation

The resident will complete one medication usage evaluation during the first half of the residency year, and present the completed MUE results at the ASHP Midyear/Vizient meeting via a poster presentation.

Longitudinal research project

The resident will complete one longitudinal research project throughout the residency year. This project may be original research or a development/enhancement of pharmacy services. Completed results will be presented as a poster presentation at the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference. The resident will also be required to complete a manuscript suitable for publication.

Continuing education

The resident will present two ACPE accredited presentations during the residency year. The topic should surround a controversial oncology topic, new medication, or guideline update.

Staffing

The resident will participate in both ambulatory and inpatient oncology staffing. The resident will be expected to staff 2 decentralized shifts per month, 1 decentralized weekend every 4 weeks, and 1 at-home on call weekend every 4 weeks. The resident will also staff 1 major and 1 minor holiday per year.

Teaching certificate

If the resident did not complete a teaching certificate program during their PGY-1 pharmacy residency program, there will be an opportunity to participate in a teaching certificate program during the PGY-2 year. We determine the provider of the teaching certificate program on a yearly basis. The resident is not required to participate in this program.

Benefits

Stipend: $53,000

Earned time: 10 days plus 4 institutional holidays

Professional travel:

• Hematology Oncology Pharmacy Conference of New England (HOPCON)
• ASHP Midyear Clinical Meeting and Vizient Consortium Pharmacy Network Meeting
• Hematology/Oncology Pharmacy Association (HOPA) Annual Conference

How to apply

Please submit all application materials via PhORCAS.

Application deadline: January 2nd.

You must have a valid pharmacy license to practice in the state of New Hampshire by July 15.

Application requirements:

• ASHP Residency Matching Program registration
• PhORCAS Residency Program application
• Letter of intent
• Curriculum vitae
• College transcripts
• Three letters of recommendation
• Supplemental application (DOCX)

Applications for candidates with a GPA of less than 3.0 on a 4.0 scale, or less than 3.7 on a 5.0 scale will not be accepted. Applications for candidates who have not yet completed a PGY-1 Hematology/Oncology, Investigational Pharmacy, OR Specialty Pharmacy rotation prior to midyear will also not be accepted.